Lyon, Rhone-Alpes, France Among the most popular portfolio startups of the fund, we may highlight CarThera, Horama, Antabio. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Health Care, Genetics.
The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Sham Innovation Santu00e9, startups are often financed by Octalfa, Bpifrance, Wellcome Trust. The meaningful sponsors for the fund in investment in the same round are Octalfa, Pontifax, Omnes Capital. In the next rounds fund is usually obtained by Octalfa, V-Bio Ventures, Sofimac Partners.
Related Funds
| Fund Name | Location |
| ActoMezz | France, Ile-de-France, Paris |
| Business Angels Club Berlin | Berlin, Berlin, Germany |
| Forebright Capital | China, Guangdong, Shenzhen |
| Haisco | China, Liaoning, Wenxiang |
| Huck Capital | California, San Francisco, United States |
| HYGE Interface | Japan, Tokyo |
| KOLBE | - |
| Matomy | Israel, Tel Aviv, Tel Aviv District |
| Particle | - |
| Pentair | Richmond upon Thames, Twickenham, United Kingdom |
| Saudi Aramco | Ash Sharqiyah, Dhahran, Saudi Arabia |
| Seven Peaks Ventures | Bend, Oregon, United States |
| Spearhead | California, San Francisco, United States |
| Taiya Dingfu | China, Fujian, Xiamen |
| Taofen8.com | China, Hangzhou, Zhejiang |
| Tehua Investment | Beijing, Beijing, China |
| Xinhu Zhongbao Co Ltd | China, Hangzhou, Zhejiang |
| Xinyi Fund | China, Hongkou District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Therapixel | $17M | 12 May 2022 | Nice, Provence-Alpes-Côte d'Azur, France | ||
Cairdac | $20M | 31 Mar 2022 | Antony, Ile-de-France, France | ||
Amolyt Pharma | $80M | 16 Sep 2021 | Écully, Rhone-Alpes, France | ||
Coave Therapeutics | $38M | 21 Jul 2021 | Bretagne, Brittany, France | ||
Mablink Bioscience | $4M | 27 Apr 2021 | Lyon, Rhone-Alpes, France | ||
AbolerIS Pharma | $2M | 04 Nov 2020 | Nantes, Pays de la Loire, France | ||
Alizé Pharma | $79M | 31 Jul 2019 | France, Auvergne-Rhône-Alpes, France | ||
CarThera | $10M | 12 Dec 2018 | France, Ile-de-France | ||
Antabio | $6M | 12 Jul 2018 | France, Auvergne-Rhône-Alpes |
– Mablink Bioscience is a Lyon, France-based company developing antibody-drug conjugates (ADC).
– The company raised €4M in a seed financing round.
– Elaia Partners led the round with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création.
– The new investment will be used to move forward its ADC pipeline.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Therapixel | $17M | 12 May 2022 | Nice, Provence-Alpes-Côte d'Azur, France | ||
Cairdac | $20M | 31 Mar 2022 | Antony, Ile-de-France, France | ||
Amolyt Pharma | $80M | 16 Sep 2021 | Écully, Rhone-Alpes, France | ||
Coave Therapeutics | $38M | 21 Jul 2021 | Bretagne, Brittany, France | ||
Mablink Bioscience | $4M | 27 Apr 2021 | Lyon, Rhone-Alpes, France | ||
AbolerIS Pharma | $2M | 04 Nov 2020 | Nantes, Pays de la Loire, France | ||
Alizé Pharma | $79M | 31 Jul 2019 | France, Auvergne-Rhône-Alpes, France | ||
CarThera | $10M | 12 Dec 2018 | France, Ile-de-France | ||
Antabio | $6M | 12 Jul 2018 | France, Auvergne-Rhône-Alpes |
